@article{Petrakis2017-wm,
title = {Losing a foot versus losing a dollar; a systematic review of cost studies in diabetic foot complications},
author = {Ioannis Petrakis and Ilias Kyriopoulos and Alexandros Ginis and Kostas Athanasakis},
year = {2017},
date = {2017-03-01},
urldate = {2017-03-01},
journal = {Expert Rev Pharmacoecon Outcomes Res},
volume = {17},
number = {2},
pages = {165--180},
address = {England},
abstract = {Diabetes mellitus is a chronic disease with high prevalence
worldwide and a range of serious related complications. Amongst
them, diabetic foot is one of the most disabling, posing a
substantial health and economic burden on patients and healthcare
systems. Areas covered: According to projections, the expected
lower limb morbidity is about to increase - in this light the
present review aimed at identifying cost-of-illness studies on
the management and treatment of conditions related to the
diabetic foot, in an aim to provide a body of evidence for an
increasing health care burden. Expert commentary: Recent
literature review surfaced a plethora of cost studies. Despite
heterogeneity of foot complications and geographic variations,
the search methodology revealed substantial costs and further
healthcare burden for people with diabetes. Amputations due to
suboptimally treated foot infections contribute to the already
high rates of hospitalizations and readmissions. The cost of
amputation ranges between $35,000 and $45,000 in the developed
countries, however it largely depends on the amputation type.
Moreover, the findings suggest that the cost of amputation in the
US is generally higher compared to the cost in European
countries. The cost of amputation in developing countries is
substantially lower, as it approximates $5,000.},
keywords = {Cost; diabetes; diabetic foot; expenditure; health care expenditure},
pubstate = {published},
tppubtype = {article}
}
Diabetes mellitus is a chronic disease with high prevalence
worldwide and a range of serious related complications. Amongst
them, diabetic foot is one of the most disabling, posing a
substantial health and economic burden on patients and healthcare
systems. Areas covered: According to projections, the expected
lower limb morbidity is about to increase - in this light the
present review aimed at identifying cost-of-illness studies on
the management and treatment of conditions related to the
diabetic foot, in an aim to provide a body of evidence for an
increasing health care burden. Expert commentary: Recent
literature review surfaced a plethora of cost studies. Despite
heterogeneity of foot complications and geographic variations,
the search methodology revealed substantial costs and further
healthcare burden for people with diabetes. Amputations due to
suboptimally treated foot infections contribute to the already
high rates of hospitalizations and readmissions. The cost of
amputation ranges between $35,000 and $45,000 in the developed
countries, however it largely depends on the amputation type.
Moreover, the findings suggest that the cost of amputation in the
US is generally higher compared to the cost in European
countries. The cost of amputation in developing countries is
substantially lower, as it approximates $5,000.